Table 3.
Restricted Mean Survival Time Analysis for Bleeding and All-Cause Death
| Outcome | Comparison Groupa | ΔRMST (d) | 95% CI | RMST Cardiac | RMST Noncardiac | RMST Exogenous |
|---|---|---|---|---|---|---|
| Any bleeding | Noncardiac | −0.25 | −3.04 to 2.06 | 22.74 | 22.49 | 24.66 |
| Exogenous | 1.91 | −0.34 to 4.23 | 22.74 | 22.49 | 24.66 | |
| Procedure-related bleeding | Noncardiac | −0.08 | −2.46 to 1.87 | 23.70 | 23.62 | 24.68 |
| Exogenous | 0.98 | −1.25 to 3.21 | 23.70 | 23.62 | 24.68 | |
| Nonprocedure-related bleeding | Noncardiac | −1.41 | −3.47 to 0.31 | 26.70 | 25.28 | 27.66 |
| Exogenous | 0.96 | 0.34-1.62 | 26.70 | 25.28 | 27.66 | |
| All-cause death | Noncardiac | −0.19 | −1.97 to 1.42 | 8.05 | 7.86 | 8.11 |
| Exogenous | 0.06 | −1.87 to 2.17 | 8.05 | 7.86 | 8.11 |
| Comparison Groupb | ΔRMST (d) | 95% CI | RMST IABP Use | RMST No IABP | |
|---|---|---|---|---|---|
| Any bleeding | IABP use | −2.69 | −4.29 to −1.11 | 20.89 | 23.58 |
| Procedure-related bleeding | IABP use | −2.13 | −3.53 to −0.66 | 22.40 | 24.54 |
| Nonprocedure-related bleeding | IABP use | −1.74 | −2.71 to −0.82 | 25.26 | 26.99 |
| All-cause death | IABP use | 5.58 | 4.26-6.77 | 12.63 | 7.04 |
Reference, cardiac stratum.
Reference, no intra-aortic balloon pumping (IABP) group. ΔRestricted mean survival time (RMST) = RMST (Comparison) – RMST (Reference). Positive values indicate longer mean event-free survival in the comparison group.